---
title: "WWGX: Indirect controlling shareholder is expected to change"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255330748.md"
description: "WWGX announced that on August 30, 2025, it received a notice from its controlling shareholder, Wanwei Group, that Wanwei Group plans to reorganize with other provincial state-owned enterprise groups. This reorganization may lead to changes in the indirect controlling shareholder and changes in the shares held by Wanwei Group, but it will not result in a change of the actual controller. Relevant arrangements still need to go through procedures and obtain approval from the relevant authorities"
datetime: "2025-08-31T07:33:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255330748.md)
  - [en](https://longbridge.com/en/news/255330748.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255330748.md)
---

# WWGX: Indirect controlling shareholder is expected to change

WWGX announced that on August 30, 2025, it received a notice from its controlling shareholder, Wanwei Group, indicating that Wanwei Group plans to restructure with other provincial state-owned enterprise groups. This restructuring may lead to changes in the indirect controlling shareholder and changes in the shares held by Wanwei Group, but it will not result in a change of the actual controller. Relevant arrangements still need to go through procedures and obtain approval from the relevant authorities

### Related Stocks

- [600063.CN](https://longbridge.com/en/quote/600063.CN.md)

## Related News & Research

- [CMOC Group (CMCLF): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/286625840.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md)
- [Valhalla Metals Announces Closing of First Tranche of Over-Subscribed Private Placement | VMXXF Stock News](https://longbridge.com/en/news/286904505.md)
- [4basebio signs clinical supply agreement for Phase II immunotherapy trial opDNA material](https://longbridge.com/en/news/287052696.md)